4//SEC Filing
Schatzman Randall C 4
Accession 0000899243-22-007519
CIK 0001641281other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 9:18 PM ET
Size
5.6 KB
Accession
0000899243-22-007519
Insider Transaction Report
Form 4
Schatzman Randall C
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-18+630,000→ 630,000 totalExercise: $3.08Exp: 2032-02-17→ Common Stock (630,000 underlying)
Footnotes (1)
- [F1]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2022.
Documents
Issuer
Bolt Biotherapeutics, Inc.
CIK 0001641281
Entity typeother
Related Parties
1- filerCIK 0001604763
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 9:18 PM ET
- Size
- 5.6 KB